Log in or Sign up for Free to view tailored content for your specialty!
Chronic Kidney Disease News
CMS increases payment for dialysis facilities, includes oral-only drugs in the bundle
CMS issued a final rule increasing the End-stage Renal Disease Prospective Payment System base rate to dialysis facilities by about 2.7% to $273.82 beginning Jan. 1, 2025, according to an agency press release.
Pegcetacoplan may lower proteinuria substantially in C3 glomerulopathy
SAN DIEGO — Pegcetacoplan may offer a clinical strategy to stabilize kidney function and reduce proteinuria significantly for patients with C3 glomerulopathy or primary immune complex membranoproliferative glomerulonephritis, data show.
Log in or Sign up for Free to view tailored content for your specialty!
VIDEO: High-volume hemodiafiltration therapy can benefit US patients
SAN DIEGO — In this video exclusive from ASN Kidney Week, nephrologists underscore the beneficial potential of using of high-volume hemodiafiltration therapy in the United States.
Semaglutide cuts major kidney complications risk for adults with type 2 diabetes, CKD
SAN DIEGO — Semaglutide was associated with lower risk for major kidney complications for adults with type 2 diabetes and chronic kidney disease without regard to baseline kidney function, data show.
Black adults who develop CKD young may be at higher risk for eGFR decline vs. white adults
SAN DIEGO — Black veterans who develop chronic kidney disease at a young age may be at a higher risk for eGFR decline than white veterans, according to data presented at Kidney Week.
FDA panel votes against sotagliflozin for glucose control in type 1 diabetes, CKD
The FDA’s Endocrinologic and Metabolic Drugs Advisory Committee recommended not approving sotagliflozin for glucose control as an adjunct to insulin in adults with type 1 diabetes and CKD.
Kidney group urges CMS to prioritize Increasing Organ Transplant Access payment model
The Kidney Transplant Collaborative expressed disappointment at the delayed CMS launch of the Increasing Organ Transplant Access model, according to a press release from the organization.
VIDEO: ASN group responds to natural disasters, shortages
SAN DIEGO — In this video exclusive from ASN Kidney Week, Jeffrey Silberzweig, MD, FACP, FASN, discusses the work the American Society of Nephrology’s Emergency Partnership Initiative is doing to respond to major health emergencies.
5 years after rejection, sotagliflozin for type 1 diabetes gets new FDA panel hearing
Five years after receiving a complete response letter from the agency, Lexicon Pharmaceuticals brought sotagliflozin back before an FDA advisory panel to seek an indication to treat patients with type 1 diabetes and chronic kidney disease.
VIDEO: Staffing is biggest challenge for dialysis nurses
SAN DIEGO — In this video exclusive from ASN Kidney Week, Healio | Nephrology News & Issues Editorial Board Member Sheila Deziel, MSN, RN, CNN, FNKF, discusses issues facing dialysis nurses.
-
Headline News
Q&A: ‘We have to be worried’ about decline in measles vaccination
November 19, 20244 min read -
Headline News
Physicians encouraged to ‘embrace’ technology in practice management
November 19, 20245 min read -
Headline News
Artificial neural network has ‘excellent’ performance in predicting COPD exacerbations
November 20, 20242 min read
-
Headline News
Q&A: ‘We have to be worried’ about decline in measles vaccination
November 19, 20244 min read -
Headline News
Physicians encouraged to ‘embrace’ technology in practice management
November 19, 20245 min read -
Headline News
Artificial neural network has ‘excellent’ performance in predicting COPD exacerbations
November 20, 20242 min read